全文获取类型
收费全文 | 66602篇 |
免费 | 4852篇 |
国内免费 | 172篇 |
专业分类
耳鼻咽喉 | 839篇 |
儿科学 | 1887篇 |
妇产科学 | 1638篇 |
基础医学 | 10793篇 |
口腔科学 | 1730篇 |
临床医学 | 6356篇 |
内科学 | 13477篇 |
皮肤病学 | 1235篇 |
神经病学 | 6242篇 |
特种医学 | 2807篇 |
外国民族医学 | 46篇 |
外科学 | 8493篇 |
综合类 | 635篇 |
一般理论 | 84篇 |
预防医学 | 5299篇 |
眼科学 | 1226篇 |
药学 | 4745篇 |
中国医学 | 163篇 |
肿瘤学 | 3931篇 |
出版年
2022年 | 475篇 |
2021年 | 1064篇 |
2020年 | 664篇 |
2019年 | 948篇 |
2018年 | 1159篇 |
2017年 | 821篇 |
2016年 | 964篇 |
2015年 | 1142篇 |
2014年 | 1405篇 |
2013年 | 2450篇 |
2012年 | 3087篇 |
2011年 | 3176篇 |
2010年 | 2297篇 |
2009年 | 1951篇 |
2008年 | 2867篇 |
2007年 | 3041篇 |
2006年 | 3005篇 |
2005年 | 2845篇 |
2004年 | 2915篇 |
2003年 | 2653篇 |
2002年 | 2738篇 |
2001年 | 2226篇 |
2000年 | 2290篇 |
1999年 | 2070篇 |
1998年 | 962篇 |
1997年 | 800篇 |
1996年 | 722篇 |
1995年 | 734篇 |
1994年 | 615篇 |
1993年 | 651篇 |
1992年 | 1543篇 |
1991年 | 1449篇 |
1990年 | 1414篇 |
1989年 | 1408篇 |
1988年 | 1195篇 |
1987年 | 1182篇 |
1986年 | 1110篇 |
1985年 | 1004篇 |
1984年 | 763篇 |
1983年 | 694篇 |
1982年 | 493篇 |
1981年 | 476篇 |
1980年 | 404篇 |
1979年 | 655篇 |
1978年 | 404篇 |
1977年 | 385篇 |
1975年 | 396篇 |
1974年 | 436篇 |
1973年 | 385篇 |
1972年 | 365篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Geert Verreck Annelies Decorte Koen Heymans Jef Adriaensen Dirk Cleeren Adri Jacobs Dehua Liu David Tomasko Albertina Arien Jef Peeters Patrick Rombaut Guy Van den Mooter Marcus E Brewster 《European journal of pharmaceutical sciences》2005,26(3-4):349-358
The aim of the current research project was to explore the possibilities of combining pressurized carbon dioxide with hot stage extrusion during manufacturing of solid dispersions of itraconazole and polyvinylpyrrolidone-co-vinyl acetate 64 (PVP-VA 64) and to evaluate the ability of the pressurized gas to act as a temporary plasticizer as well as to produce a foamed extrudate. Pressurized carbon dioxide was injected into a Leistritz Micro 18 intermeshing co-rotating twin-screw melt extruder using an ISCO 260D syringe pump. The physicochemical characteristics of the extrudates with and without injection of carbon dioxide were evaluated with reference to the morphology of the solid dispersion and dissolution behaviour and particle properties. Carbon dioxide acted as plasticizer for itraconazole/PVP-VA 64, reducing the processing temperature during the hot stage extrusion process. Amorphous dispersions were obtained and the solid dispersion was not influenced by the carbon dioxide. Release of itraconazole from the solid dispersion could be controlled as a function of processing temperature and pressure. The macroscopic morphology changed to a foam-like structure due to expansion of the carbon dioxide at the extrusion die. This resulted in increased specific surface area, porosity, hygroscopicity and improved milling efficiency. 相似文献
52.
53.
P A Rittenhouse E A Bakkum L D Van de Kar 《The Journal of pharmacology and experimental therapeutics》1991,259(1):58-65
DOI [(+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCI] is a serotonin (5-HT1C/5-HT2) agonist, with potent cardiovascular effects. The purpose of the present studies was to determine the identity and location of the 5-HT receptor subtype(s) mediating the renin and blood pressure responses to DOI. Injection (i.p.) of DOI to conscious male rats elevated plasma renin activity in a dose-dependent manner. The 5-HT1C/5-HT2 antagonist ritanserin completely blocked the DOI-induced increase in plasma renin activity. In order to distinguish the 5-HT2- from the 5-HT1C- mediated effect of DOI, spiperone was administered before DOI. Low doses of spiperone (0.01 and 0.1 mg/kg, s.c.) significantly reduced the renin response to DOI. Because spiperone has a higher affinity for 5-HT2 than 5-HT1C receptors, these data suggest that DOI stimulates renin secretion through 5-HT2 receptors. To separate central from peripheral 5-HT receptors, we injected DOI into rats pretreated with saline or xylamidine, a 5-HT2 antagonist which does not cross the blood-brain barrier. Xylamidine produced a shift to the right and suppression of the maximal effect of DOI on plasma renin activity, suggesting a role for peripheral 5-HT2 receptors in the effect of DOI. On the other hand, i.c.v. administration of DOI, using doses lower than the peripherally effective doses, caused a significant elevation of plasma renin activity at 200 micrograms/kg. These experiments suggest that DOI's elevation of plasma renin activity has both peripheral and central sites of action.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
54.
5-Amino-4-imidazolecarboxamide (AICA) riboside, the nucleoside corresponding to AICA ribotide (AICAR or ZMP), an intermediate of the de novo pathway of purine biosynthesis, was found to exert a dose-dependent inhibition on gluconeogenesis in isolated rat hepatocytes. Production of glucose from lactate-pyruvate mixtures was half-maximally inhibited by approximately 100 microM and completely suppressed by 500 microM AICA riboside. AICA riboside also inhibited the production of glucose from all other gluconeogenic precursors investigated, i.e., fructose, dihydroxyacetone, and L-proline. Measurements of intermediates of the glycolytic-gluconeogenic pathway showed that AICA riboside provoked elevations of triose phosphates and fructose-1,6-bisphosphate and decreases in fructose-6-phosphate and glucose-6-phosphate. The effects of AICA riboside persisted when the cells were washed 10 min after its addition but were suppressed by 5-iodotubercidin, an inhibitor of adenosine kinase. AICA riboside provoked a dose-dependent buildup of normally undetectable Z nucleotides. After 20 min of incubation with 500 microM AICA riboside, ZMP, ZTP, and ZDP reached 3, 0.3, and 0.1 mumol/g cells, respectively. Concentrations of ATP were not significantly modified by addition of up to 500 microM AICA riboside when the cells were incubated with lactate-pyruvate but decreased with fructose or dihydroxyacetone. The activity of rat liver fructose-1,6-bisphosphatase was inhibited by ZMP with an apparent Ki of 370 microM. It is concluded that AICA riboside exerts a suppressive effect on gluconeogenesis because it provokes an accumulation of ZMP, which inhibits fructose-1,6-bisphosphatase.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
55.
56.
57.
58.
W. A. A. Tjalma M. Arbyn† J. Paavonen‡ T. R. Van Waes & J. J. Bogers§ 《International journal of gynecological cancer》2004,14(5):751-761
Persistent infection with one of the oncogenic human papillomavirus (HPV) types is a necessity for the development of cervical cancer. By HPV vaccination, cervical cancer could become a very rare disease. Two types of HPV vaccines can be distinguished: (i) therapeutic vaccines which induce cellular immunity targeted against epithelial cells infected with HPV and (ii) prophylactic vaccines inducing virus-neutralizing antibodies protecting against new but not against established infections. At present, several vaccines have been developed and tested in clinical trials. The vaccines are generally well tolerated and highly immunogenic. The current clinical data indicate that prophylactic vaccines are very effective against new persistent infections and the development of cervical intraepithelial lesions. The protection is type specific. However, the follow-up of the vaccination trials is still short. The effect of HPV vaccines on future cancer incidence will only be known after decades of follow-up. This article will address the status of recently terminated phase II and currently running phase III trials with prophylactic HPV vaccines. 相似文献
59.
60.